New MRI-Guided catheter aims to zap heart rhythm problem

NCT ID NCT05904548

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new catheter that uses real-time MRI to guide treatment for a common heart rhythm problem called type I atrial flutter. About 91 adults who need this procedure will receive radiofrequency ablation to block abnormal electrical signals. The main goals are to see if the procedure is safe and effectively restores normal heart rhythm.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
RF ablation catheter
What this could lead to
If it works, this could offer a more precise, safer way to treat atrial flutter using real-time MRI guidance.
What could go wrong
This is an early-stage, single-arm trial with only 91 participants. Risks include serious heart complications, and it may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FLUTTER TYPICAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Amsterdam University Medical Center (AUMC)

    RECRUITING

    Amsterdam, Netherlands

  • Johns Hopkins University (JHU)

    RECRUITING

    Baltimore, Maryland, 21218, United States

  • University Hospital of Vaud (CHUV)

    RECRUITING

    Lausanne, 1011, Switzerland

  • University of Virginia (UVA)

    NOT_YET_RECRUITING

    Charlottesville, Virginia, 22903, United States

  • Virginia Commonwealth University

    NOT_YET_RECRUITING

    Richmond, Virginia, 23284, United States

  • l'institut Cardiologique Paris Sud (ICPS)

    RECRUITING

    Massy, 91300, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.